Suggestions

Du même auteur

Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.

Archive ouverte | Gruson, B. | CCSD

International audience. Mastocytosis can lead to organ failure as well as systemic symptoms that can be disabling, with considerable deterioration in quality of life. Beside symptomatic treatments, interferon- and p...

Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.

Archive ouverte | Rossignol, J. | CCSD

International audience

CD30 Expression in Cutaneous Lesions of Systemic Mastocytosis: Clinical, Biological and Histopathological Analysis of 27 Patients

Archive ouverte | Poirier, E. | CCSD

International audience

Chargement des enrichissements...